Biochemical safety profiles of gadolinium‐based extracellular contrast agents and nephrogenic systemic fibrosis
Top Cited Papers
Open Access
- 29 October 2007
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 26 (5) , 1190-1197
- https://doi.org/10.1002/jmri.21135
Abstract
Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd‐based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side effects and adverse reactions from Gd is now an important requirement for practicing radiologists. In addition to the ongoing accumulation and analyses of clinical NSF data, it is also essential for the practicing radiologist to understand the biochemical characteristics of the extracellular Gd‐chelates. The purpose of this review is to consolidate and update the available information on known side effects, adverse reactions, and toxicity of the Gd chelates, with particular emphasis on the potential mechanisms of NSF. J. Magn. Reson. Imaging 2007;26:1190–1197.Keywords
This publication has 97 references indexed in Scilit:
- MR contrast agents: Physical and pharmacologic basicsJournal of Magnetic Resonance Imaging, 2007
- Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?Magnetic Resonance Materials in Physics, Biology and Medicine, 2007
- Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosisJournal of the American Academy of Dermatology, 2007
- Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamideEuropean Radiology, 2006
- Gadolinium‐based contrast agents and nephrotoxicity in patients undergoing coronary artery proceduresCatheterization and Cardiovascular Interventions, 2006
- GadofosvesetDrugs, 2006
- Quantification of gadodiamide as Gd in serum, peritoneal dialysate and faeces by inductively coupled plasma atomic emission spectroscopy and comparative analysis by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2000
- Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast AgentInvestigative Radiology, 1993
- Preservation of sickle cell blood-flow patterns during MR imaging: an in vivo studyAmerican Journal of Roentgenology, 1988
- Induced Alignment of Flowing Sickle Erythrocytes in a Magnetic Field A Preliminary ReportInvestigative Radiology, 1985